Get started
Author

Miriam R. Schäfer

Observed names: M R Schäfer, M. R. Schafer, M. R. Schäfer, M.R. Schafer, M.R. Schäfer, MR Schäfer (11606689), Miriam R Schäfer, Miriam R. Schafer, Miriam Schafer, Miriam Schäfer, Monica R Schäffer
Observed institutions: University of Vienna, The University of Melbourne, Vienna General Hospital, Orygen Youth Health, Orygen, Jena University Hospital, Melbourne Health, Medical University of Vienna
OpenAlex ID: A5103924146
Long-Chain ω-3 Fatty Acids for Indicated Prevention of Psychotic Disorders
2010 · G. Paul Amminger, Miriam R. Schäfer, et al. · Archives of General Psychiatry · 906
PDF
Omega-3 Fatty Acids Supplementation in Children with Autism: A Double-blind Randomized, Placebo-controlled Pilot Study
2006 · G. Paul Amminger, Gregor E. Berger, et al. · Biological Psychiatry · 366
Effect of ω-3 Polyunsaturated Fatty Acids in Young People at Ultrahigh Risk for Psychotic Disorders
2016 · Patrick D. McGorry, Barnaby Nelson, et al. · JAMA Psychiatry · 264
PDF
Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study
2015 · G. Paul Amminger, Miriam R. Schäfer, et al. · Nature Communications · 200
PDF
Emotion Recognition in Individuals at Clinical High-Risk for Schizophrenia
2011 · G. P. Amminger, M. R. Schafer, et al. · Schizophrenia Bulletin · 193
PDF
Decreased nervonic acid levels in erythrocyte membranes predict psychosis in help-seeking ultra-high-risk individuals
2011 · G P Amminger, M R Schäfer, et al. · Molecular Psychiatry · 161
Omega-6 to omega-3 polyunsaturated fatty acid ratio and subsequent mood disorders in young people with at-risk mental states: a 7-year longitudinal study
2017 · M E Berger, S Smesny, et al. · Translational Psychiatry · 135
PDF
Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis
2013 · S Smesny, B Milleit, et al. · Molecular Psychiatry · 80
Usefulness of the CAPE-P15 for detecting people at ultra-high risk for psychosis: Psychometric properties and cut-off values
2017 · Akvile Bukenaite, Jan Stochl, et al. · Schizophrenia Research · 78
Facial and vocal affect perception in people at ultra‐high risk of psychosis, first‐episode schizophrenia and healthy controls
2012 · G. Paul Amminger, Miriam R. Schäfer, et al. · Early Intervention in Psychiatry · 75
Youth Depression Alleviation with Anti-inflammatory Agents (YoDA-A): a randomised clinical trial of rosuvastatin and aspirin
2020 · Michael Berk, Mohammadreza Mohebbi, et al. · BMC Medicine · 73
PDF
Emotion recognition as a predictor of transition to a psychotic disorder in ultra-high risk participants
2014 · Kelly A. Allott, Miriam R. Schäfer, et al. · Schizophrenia Research · 70
Neurocognition as a predictor of transition to psychotic disorder and functional outcomes in ultra-high risk participants: Findings from the NEURAPRO randomized clinical trial
2018 · Luke K. Bolt, G. Paul Amminger, et al. · Schizophrenia Research · 69
Emotion recognition in unaffected first-degree relatives of individuals with first-episode schizophrenia
2014 · Kelly A. Allott, Simon Rice, et al. · Schizophrenia Research · 69
Omega-3 Fatty Acid Supplementation in Adolescents with Borderline Personality Disorder and Ultra-High Risk Criteria for Psychosis: A Post Hoc Subgroup Analysis of a Double—Blind, Randomized Controlled Trial
2013 · G Paul Amminger, Andrew M Chanen, et al. · The Canadian Journal of Psychiatry · 68
The NEURAPRO Biomarker Analysis: Long-Chain Omega-3 Fatty Acids Improve 6-Month and 12-Month Outcomes in Youths at Ultra-High Risk for Psychosis
2019 · G. Paul Amminger, Barnaby Nelson, et al. · Biological Psychiatry · 67
Prediction of transition from ultra-high risk to first-episode psychosis using a probabilistic model combining history, clinical assessment and fatty-acid biomarkers
2016 · S R Clark, B T Baune, et al. · Translational Psychiatry · 59
PDF
Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids
2015 · G P Amminger, A Mechelli, et al. · Translational Psychiatry · 58
PDF
NEURAPRO: a multi-centre RCT of omega-3 polyunsaturated fatty acids versus placebo in young people at ultra-high risk of psychotic disorders—medium-term follow-up and clinical course
2018 · B. Nelson, G. P. Amminger, et al. · Schizophrenia · 57
PDF
St. John's Wort (Hypericum Perforatum) - Is it Safe during Breastfeeding?
2002 · C. M. Klier, M. R. Schäfer, et al. · Pharmacopsychiatry · 56
Comparison of erythrocyte omega-3 index, fatty acids and molecular phospholipid species in people at ultra-high risk of developing psychosis and healthy people
2019 · Ayedh Alqarni, Todd W. Mitchell, et al. · Schizophrenia Research · 53
White matter integrity in individuals at ultra-high risk for psychosis: a systematic review and discussion of the role of polyunsaturated fatty acids
2016 · Nandita Vijayakumar, Cali Bartholomeusz, et al. · BMC Psychiatry · 53
PDF
Adolescents at ultra-high risk for psychosis with and without 22q11 deletion syndrome: A comparison of prodromal psychotic symptoms and general functioning
2012 · Marco Armando, Paolo Girardi, et al. · Schizophrenia Research · 51
PDF
Differential expression of the inflammation marker IL12p40 in the at-risk mental state for psychosis: a predictor of transition to psychotic disorder?
2016 · Melanie Föcking, Patrick Dicker, et al. · BMC Psychiatry · 46
PDF
Niacin Skin Sensitivity Is Increased in Adolescents at Ultra-High Risk for Psychosis
2016 · Gregor E. Berger, Stefan Smesny, et al. · PLoS ONE · 46
PDF
Works count: 89
Citation count: 4,102
H-index: 31
I10-index: 56
Year
Topic
Type